Advertisement

Topics

Zymeworks licenses its Azymetric and EFECT platforms to Janssen

09:16 EST 13 Nov 2017 | thePharmaLetter

Zymeworks has added to its long list of collaborations with global pharma majors, signing a deal with…

Original Article: Zymeworks licenses its Azymetric and EFECT platforms to Janssen

NEXT ARTICLE

More From BioPortfolio on "Zymeworks licenses its Azymetric and EFECT platforms to Janssen"

Advertisement
Quick Search
Advertisement
Advertisement